Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Author is McCune, Jeannine S  [Clear All Filters]
B
Beard, BC, Trobridge GD, Ironside C, McCune JS, Adair JE, Kiem H-P.  2010.  Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.. The Journal of clinical investigation. 120(7):2345-54. Abstract
Bubalo, JS, Cherala G, McCune JS, Munar MY, Tse S, Maziarz R.  2012.  Aprepitant pharmacokinetics and assessing the impact of aprepitant on cyclophosphamide metabolism in cancer patients undergoing hematopoietic stem cell transplantation.. Journal of clinical pharmacology. 52(4):586-94. Abstract
C
Chow, EJ, Pihoker C, Friedman DL, Lee SJ, McCune JS, Wharton C, Roth CL, Baker KS.  2012.  Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia.. Pediatric blood & cancer. Abstract
G
Graves, SS, Stone D, Loretz C, Peterson L, McCune JS, Mielcarek M, Storb R.  2009.  Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.. Transplantation. 88(3):317-22. Abstract
H
Ho, BE, Shen DD, McCune JS, Bui T, Risler L, Yang Z, Ho RJY.  2010.  Effects of Garlic on Cytochromes P450 2C9- and 3A4-Mediated Drug Metabolism in Human Hepatocytes.. Scientia pharmaceutica. 78(3):473-481. Abstract
L
Li, H, Mager DE, Bemer MJ, Salinger DH, Vicini P, Sandmaier BM, Nash R, McCune JS.  2012.  A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.. Journal of clinical pharmacology. 52(11):1654-64. Abstract
M
McCune, JS, Baker KS, Blough DK, Gamis A, Bemer MJ, Kelton-Rehkopf MC, Winter L, Barrett JS.  2012.  Variation in Prescribing Patterns and Therapeutic Drug Monitoring of Intravenous Busulfan in Pediatric Hematopoietic Cell Transplant Recipients.. Journal of clinical pharmacology. Abstract
McCune, JS, Woodahl EL, Furlong T, Storer BE, Wang J, Heimfeld S, Deeg HJ, O'Donnell PV.  2012.  A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients.. Cancer chemotherapy and pharmacology. 69(1):263-272. Abstract
McCune, JS, Sullivan SD, Blough DK, Clarke L, McDermott C, Malin J, Ramsey S.  2012.  Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.. Pharmacotherapy. 32(1):7-19. Abstract
McCune, JS, Batchelder A, Guthrie KA, Witherspoon RP, Appelbaum FR, Phillips B, Vicini P, Salinger DH, McDonald GB.  2009.  Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22. Abstract
McCune, JS, Holmberg L.  2009.  Busulfan in hematopoietic stem cell transplant setting.. Expert opinion on drug metabolism & toxicology. 5(8):957-69. Abstract
McCune, JS, Baker KS, Blough DK, Gamis A, Bemer MJ, Kelton-Rehkopf MC, Winter L, Barrett JS.  2013.  Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients.. Journal of clinical pharmacology. 53(3):264-75. Abstract
McDermott, CL, Sandmaier BM, Storer B, Li H, Mager DE, Boeckh MJ, Bemer MJ, Knutson J, McCune JS.  2013.  Non-relapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
R
Raccor, BS, Claessens AJ, Dinh JC, Park JR, Hawkins DS, Thomas SS, Makar KW, McCune JS, Totah RA.  2012.  Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation: in vitro and in vivo investigations.. Drug metabolism and disposition: the biological fate of chemicals. 40(1):54-63. Abstract
Ramsey, SD, McCune JS, Blough DK, McDermott CL, Clarke L, Malin JL, Sullivan SD.  2010.  Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.. The American journal of managed care. 16(9):678-86. Abstract
Ramsey, SD, McCune JS, Blough DK, McDermott CL, Beck SJ, López JA, Joachim Deeg H.  2012.  Patterns of blood product use among patients with myelodysplastic syndrome.. Vox sanguinis. 102(4):331-337. Abstract
Rezvani, AR, McCune JS, Storer BE, Batchelder A, Kida A, Deeg HJ, McDonald GB.  In Press.  Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
S
Salinger, DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Salinger, DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.  2009.  A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
Sullivan, SD, Ramsey SD, Blough DK, McDermott CL, Clarke L, McCune JS.  2011.  Health care use and primary prophylaxis with colony-stimulating factors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 14(2):247-52. Abstract
W
Woodahl, EL, Hingorani SR, Wang J, Guthrie KA, McDonald GB, Batchelder A, Li M, Schoch HG, McCune JS.  2008.  Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation.. The pharmacogenomics journal. 8(4):248-55. Abstract
Woodahl, EL, Wang J, Heimfeld S, Sandmaier BM, O'Donnell PV, Phillips B, Risler L, Blough DK, McCune JS.  2009.  A novel phenotypic method to determine fludarabine triphosphate accumulation in T-lymphocytes from hematopoietic cell transplantation patients.. Cancer chemotherapy and pharmacology. 63(3):391-401. Abstract
Woodahl, EL, Wang J, Heimfeld S, Ren AG, McCune JS.  2008.  Imatinib inhibition of fludarabine uptake in T-lymphocytes.. Cancer chemotherapy and pharmacology. 62(4):735-9. Abstract
Woodahl, EL, Wang J, Heimfeld S, Sandmaier BM, McCune JS.  2009.  Intracellular disposition of fludarabine triphosphate in human natural killer cells.. Cancer chemotherapy and pharmacology. 63(5):959-64. Abstract
Y
Yeh, RF, Pawlikowski MA, Blough DK, McDonald GB, O'Donnell PV, Rezvani A, Deeg HJ, McCune JS.  2012.  Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(2):265-272. Abstract